IBDEI0N7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10825,1,3,0)
 ;;=3^Breast Lump,Unspec
 ;;^UTILITY(U,$J,358.3,10825,1,4,0)
 ;;=4^N63.
 ;;^UTILITY(U,$J,358.3,10825,2)
 ;;=^5015791
 ;;^UTILITY(U,$J,358.3,10826,0)
 ;;=L13.9^^47^522^17
 ;;^UTILITY(U,$J,358.3,10826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10826,1,3,0)
 ;;=3^Bullous Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,10826,1,4,0)
 ;;=4^L13.9
 ;;^UTILITY(U,$J,358.3,10826,2)
 ;;=^5009105
 ;;^UTILITY(U,$J,358.3,10827,0)
 ;;=L02.93^^47^522^18
 ;;^UTILITY(U,$J,358.3,10827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10827,1,3,0)
 ;;=3^Carbuncle,Unspec
 ;;^UTILITY(U,$J,358.3,10827,1,4,0)
 ;;=4^L02.93
 ;;^UTILITY(U,$J,358.3,10827,2)
 ;;=^5009018
 ;;^UTILITY(U,$J,358.3,10828,0)
 ;;=L03.90^^47^522^19
 ;;^UTILITY(U,$J,358.3,10828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10828,1,3,0)
 ;;=3^Cellulitis,Unspec
 ;;^UTILITY(U,$J,358.3,10828,1,4,0)
 ;;=4^L03.90
 ;;^UTILITY(U,$J,358.3,10828,2)
 ;;=^5009067
 ;;^UTILITY(U,$J,358.3,10829,0)
 ;;=L94.9^^47^522^20
 ;;^UTILITY(U,$J,358.3,10829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10829,1,3,0)
 ;;=3^Connective Tissue Disorder,Localized,Unspec
 ;;^UTILITY(U,$J,358.3,10829,1,4,0)
 ;;=4^L94.9
 ;;^UTILITY(U,$J,358.3,10829,2)
 ;;=^5009475
 ;;^UTILITY(U,$J,358.3,10830,0)
 ;;=L84.^^47^522^21
 ;;^UTILITY(U,$J,358.3,10830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10830,1,3,0)
 ;;=3^Corns & Callosities
 ;;^UTILITY(U,$J,358.3,10830,1,4,0)
 ;;=4^L84.
 ;;^UTILITY(U,$J,358.3,10830,2)
 ;;=^271920
 ;;^UTILITY(U,$J,358.3,10831,0)
 ;;=L27.0^^47^522^23
 ;;^UTILITY(U,$J,358.3,10831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10831,1,3,0)
 ;;=3^Dermatitis d/t Drugs/Meds Taken Internally,General
 ;;^UTILITY(U,$J,358.3,10831,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,10831,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,10832,0)
 ;;=L27.1^^47^522^24
 ;;^UTILITY(U,$J,358.3,10832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10832,1,3,0)
 ;;=3^Dermatitis d/t Drugs/Meds Taken Internally,Local
 ;;^UTILITY(U,$J,358.3,10832,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,10832,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,10833,0)
 ;;=L27.2^^47^522^25
 ;;^UTILITY(U,$J,358.3,10833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10833,1,3,0)
 ;;=3^Dermatitis d/t Ingested Food
 ;;^UTILITY(U,$J,358.3,10833,1,4,0)
 ;;=4^L27.2
 ;;^UTILITY(U,$J,358.3,10833,2)
 ;;=^5009146
 ;;^UTILITY(U,$J,358.3,10834,0)
 ;;=L58.0^^47^522^26
 ;;^UTILITY(U,$J,358.3,10834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10834,1,3,0)
 ;;=3^Dermatitis d/t Radiation,Acute
 ;;^UTILITY(U,$J,358.3,10834,1,4,0)
 ;;=4^L58.0
 ;;^UTILITY(U,$J,358.3,10834,2)
 ;;=^5009228
 ;;^UTILITY(U,$J,358.3,10835,0)
 ;;=L58.1^^47^522^27
 ;;^UTILITY(U,$J,358.3,10835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10835,1,3,0)
 ;;=3^Dermatitis d/t Radiation,Chronic
 ;;^UTILITY(U,$J,358.3,10835,1,4,0)
 ;;=4^L58.1
 ;;^UTILITY(U,$J,358.3,10835,2)
 ;;=^5009229
 ;;^UTILITY(U,$J,358.3,10836,0)
 ;;=L58.9^^47^522^22
 ;;^UTILITY(U,$J,358.3,10836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10836,1,3,0)
 ;;=3^Dermatitis d/t  Radiation,Unspec
 ;;^UTILITY(U,$J,358.3,10836,1,4,0)
 ;;=4^L58.9
 ;;^UTILITY(U,$J,358.3,10836,2)
 ;;=^5009230
 ;;^UTILITY(U,$J,358.3,10837,0)
 ;;=L27.9^^47^522^28
 ;;^UTILITY(U,$J,358.3,10837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10837,1,3,0)
 ;;=3^Dermatitis d/t Unspec Subs Taken Internally
 ;;^UTILITY(U,$J,358.3,10837,1,4,0)
 ;;=4^L27.9
 ;;^UTILITY(U,$J,358.3,10837,2)
 ;;=^271914
 ;;^UTILITY(U,$J,358.3,10838,0)
 ;;=L20.9^^47^522^30
 ;;^UTILITY(U,$J,358.3,10838,1,0)
 ;;=^358.31IA^4^2
